GMP API Manufacturing

Drive your program from Hit-to-Lead to PCC with a team of 1,000+ chemists. We combine massive synthetic capacity with US-led strategic problem solving.

Accelerate your Make-Test-Decide cycles.

Scale is meaningless without speed. We convert our synthetic capacity into discovery velocity, tightening the loop between design and execution. This allows you to iterate faster and reach decision-enabling data without the management overhead of traditional outsourcing.

Unmatched Throughput.

From milligram library synthesis to kilogram scale-up. Our sheer capacity allows for parallel exploration of diverse chemical space, shortening your “Make” cycle significantly.

  • Responsive Project Management
  • Broad Therapeutic Expertise

Expert Design & CADD

We don’t just execute ticket orders. Our senior leaders (20% PhDs) actively contribute to SAR analysis and scaffold hopping strategies using AI-driven CADD tools.

  • Multi-Parameter Analysis (MPA)
  • Patent Creation Strategies

US-Standard IP Protection.

Your IP is secure. With US-managed data systems and strict firewall protocols, you get the economic advantage of global execution with the security of a Western partner.

  • Deep Integration with Biology Teams
  • Zero-Compromise Data Security

Hit Identification

The process of finding compounds that interact with a biological target, such as a protein.

Hit to Lead

Through evaluation and modification of “hit” compounds to enhance their potential.

Lead Optimization

Further refinement of a compound’s properties to develop a drug candidate.

Patent filing support

Guidance through the patent filing process for new drug compounds.

PTI Symphony X

  • 0.1-0.2 mmol
  • N2 protection
  • 24 channels

CEM MultiPep2

  • 0.1-0.2 mmol
  • N2 protection
  • 24 channels

Tetras Volo

  • 0.1-0.2 mmol
  • N2 protection
  • 24 channels

DL-PSI-286

  • 0.1-0.2 mmol
  • N2 protection
  • 24 channels

Download our full Medicinal Chemistry Fact Sheet

In posuere at eget vestibulum mi magnis cursus nulla. Massa viverra amet eget facilisis. Morbi morbi nulla sit amet lorem augue tortor.

Small libraries

  • 10 – 50mg of each compound
  • Purity – ≥90% (95% if desired) by HPLC/LC-MS for all compounds
  • 1H-NMR for 5- 10% (or more, if required) of the compounds

Large libraries

  • 10mg of each compound
  • Purity – ≥85% by (90% if desired) HPLC/LC-MS for all compounds
  • In general 1H-NMR for 5 – 10% of the compounds

42-Step Liquid-Phase Synthesis: Achieving 99% Purity

Challenge: Synthesizing the reference peptide MK-0616. Solution: Our team deployed a specialized liquid-phase strategy to overcome aggregation issues, delivering the target at >99% purity.

42-Step Liquid-Phase Synthesis: Achieving 99% Purity

Challenge: Synthesizing the reference peptide MK-0616. Solution: Our team deployed a specialized liquid-phase strategy to overcome aggregation issues, delivering the target at >99% purity.

Partnership solutions

Flexible ways to engage our chemistry teams

Integrated Drug Discovery (IDD)

Strategic leadership from target to candidate.

Let our project leaders drive the full DMTA cycle. We coordinate chemistry, biology, and DMPK to accelerate your path from Hit to PCC.

Functional Service Provider (FSP)

Dedicated scientists working exclusively on your systems.

Extend your internal capacity with a dedicated team of BioDuro-Sundia chemists working exclusively on your projects and systems.

IND-Enabling Programs

A complete safety & tox package for regulatory submission.

streamlined transition from PCC to IND. We combine GLP-tox batch synthesis with safety assessment to get you regulatory-ready in record time.

Request a Consultation

Speak directly with a scientific project leader about your challenges.

Request a Consultation

Download Fact Sheet

Get the full technical specifications and equipment list.

Download Fact Sheet

General Inquiries

For careers, media, or general questions not related to active projects.

See General Inquiries